1-3 of 3
Spero R. Cataland
Close
Sort by
Journal Articles

A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry

Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P. Presson, Shruti Chaturvedi, Ana G. Antun, Andrew M. Farland, Ryan Woods, Ara Metjian, Yara A. Park, Gustaaf de Ridder, Briana Gibson, Raj S. Kasthuri, Darla K. Liles, Frank Akwaa, Todd Clover, Lisa Baumann Kreuziger, Meera Sridharan, Ronald S. Go, Keith R. McCrae, Harsh Vardhan Upreti, Radhika Gangaraju, Nicole K. Kocher, X. Long Zheng, Jay S. Raval, Camila Masias, Spero R. Cataland, Andrew D. Johnson, Elizabeth Davis, Michael D. Evans, Marshall Mazepa, Ming Y. Lim
Journal: Blood Advances
Blood Adv (2024) 8 (3): 620–623.
https://doi.org/10.1182/bloodadvances.2023010807
Published: 2024
Includes: Supplemental data
Journal Articles

Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission

Clinical Trials & Observations
Senthil Sukumar, Max Brodsky, Sarah Hussain, Lisa Yanek, Alison Moliterno, Robert Brodsky, Spero R. Cataland, Shruti Chaturvedi
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1264–1270.
https://doi.org/10.1182/bloodadvances.2020004169
Published: 2022
Includes: Supplemental data
Journal Articles

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Spero R. Cataland, Peter J. Kourlas, Shangbin Yang, Susan Geyer, Leslie Witkoff, Haiwa Wu, Camila Masias, James N. George, Haifeng M. Wu
Journal: Blood Advances
Blood Adv (2017) 1 (23): 2075–2082.
https://doi.org/10.1182/bloodadvances.2017009308
Published: 2017